OR
Oryzon Genomics
ORY.MC·BMEBarcelona ESFounded 200060 employees
Micro CapbiotechPublicOncologyCNS
Platform: LSD1 Epigenetic
Market Cap
$0.1B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ORY.MC)
Loading ORY.MC stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Polainavolisib | ORY-8119 | Preclinical | 1 | CFTR | NMOSDCeliac | ||
| ORY-4744 | ORY-4744 | Phase 2/3 | 2 | PD-L1 | Celiac |
SEC Filings & Financial Documents
SEC filings are not available for BME-listed companies.
Oryzon Genomics trades on BME (ES). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)